alcohol withdrawal delirium
MONDO:0006642
An acute organic mental disorder induced by cessation or reduction in chronic alcohol consumption. Clinical characteristics include confusion; delusions; vivid hallucinations; tremor; agitation; insomnia; and signs of autonomic hyperactivity (e.g., elevated blood pressure and heart rate, dilated pupils, and diaphoresis). This condition may occasionally be fatal. It was formerly called delirium tremens. (From Adams et al., Principles of Neurology, 6th ed, p1175)
Research intelligence
Directly mapped studies only · unique clinical trialsCurrent registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.
Medications under investigation
Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.
MONDO disease family
Recruiting studies by city
Trial status
Trial phase
Study start year
Investigated drug interventions
Delirium tremens
Delirium tremens (DTs; lit. 'mental disturbance with shaking') is a rapid onset of confusion caused by withdrawal from alcohol. DT typically occurs 48–72 hours after the last use of alcohol and symptoms last 1–8 days. Typical symptoms include nightmares, confusion, disorientation, heavy sweating, elevated heart rate, and elevated blood pressure. Visual, auditory, and tactile hallucinations are also common. DT can be fatal especially without treatment. Occasionally, a very high body temperature or seizures (colloquially known as "rum fits") may result in death. Other causes of death include respiratory failure and cardiac arrhythmias. Delirium tremens typically occurs only in people with a high intake of alcohol for prolonged periods of time, followed by sharply reduced intake. A similar syndrome may occur with benzodiazepine and barbiturate withdrawal; however, the term delirium tremens is reserved for alcohol withdrawal. In a person with delirium tremens, it is important to rule out other associated problems such as electrolyte abnormalities, pancreatitis, and alcoholic hepatitis. Prevention is by treating withdrawal symptoms using similarly acting compounds to taper off the use of the precipitating substance in a controlled fashion. If delirium tremens occurs, aggressive treatment with benzodiazepines improves outcomes. Treatment in a quiet intensive care unit with sufficient light is often recommended to re-orient the patient. Benzodiazepines are the medication of choice with short acting compounds including lorazepam and oxazepam commonly used, which bypass the liver...
Background only. Canonical identity remains MONDO; clinical-trial relationships come from ClinicalTrials.gov.Drugs being studied
Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.